利好官方医疗健康反垄断

FTC与Caremark达成反垄断和解

来源：FTC · 发布：2026-07-14

美国联邦贸易委员会（FTC）与最大药房福利管理公司Caremark及其关联实体达成和解，将降低患者自付费用，提升透明度，并确保社区药房公平对待。

FTC reached a settlement with Caremark, one of the largest PBMs, reducing patients' out-of-pocket costs, increasing transparency, and ensuring fair treatment for community pharmacies.

为何重要： 该和解案是降低美国医疗成本的关键进展，强化对药品中间商的监管，推动医药供应链公平性。 This settlement is a key step in lowering U.S. healthcare costs and strengthening oversight of drug middlemen to promote fairness in the pharmaceutical supply chain.

原文来源：FTC ↗（版权归原作者/原机构所有）

Original source: FTC ↗ (copyright belongs to the original author/organization)

其他报道：SEC · WHO News · WIPO · TechCrunch · Hacker News

本页内容由 AI 自动整理自公开来源，仅供信息参考，不构成法律意见。版权归原作者/原机构所有。

Content on this page is AI-curated from public sources for information only — not legal advice. Copyright belongs to the original authors/organizations.